SpaceX Poised for Historic IPO: $75 Billion Fundraise Expected in June
Elon Musk's SpaceX is preparing for a landmark initial public offering in June, targeting $75 billion in capital raise following its $1.25 trillion valuation after merging with xAI.
Powerica IPO Subscription Update: Day 2 Shows Slow Momentum—Should You Invest?
Powerica's ₹1,100 crore IPO has attracted minimal interest on day 2 with just 1% subscription. We analyse the GMP, price band, and anchor response to help you decide.
Sai Parenteral IPO Showing Weak Demand: Should Investors Apply?
Sai Parenteral's IPO is struggling with minimal subscription on Day 2, raising concerns about investor appetite. Here's what you need to know before deciding to apply.
SpaceX IPO Filing Expected Soon: Musk's Rocket Company Could Raise Over $75 Billion
SpaceX is preparing to file for an initial public offering that could value the space exploration company at over $75 billion, with retail investors potentially securing more than 20% of the offering.
₹18,000 Crore IPO Pipeline in Jeopardy as SEBI Approvals Face Expiration
Companies with SEBI clearances expiring between April-June 2025 face mounting pressure to launch IPOs or lose approvals, potentially disrupting India's capital markets liquidity in the near term.
Amir Chand Jagdish Kumar IPO Gains Traction: 1.26x Subscription on Opening Day Signals Strong NII Interest
The Amir Chand Jagdish Kumar (Exports) IPO received robust subscription of 1.26x on its first day, driven primarily by demand from Non-Institutional Investors (NII). The issue is priced between ₹201-₹212 per share.
Sai Parenteral IPO Stumbles on Opening Day with Minimal Subscription
Sai Parenteral's ₹285 crore IPO attracted tepid investor response on day one, achieving just 0.05x subscription. Market indicators suggest a muted listing ahead.
Sai Parenteral IPO Sees Muted Opening With Just 4% Subscription on Day One
Sai Parenteral's IPO has drawn lukewarm investor response on its first day, with subscription levels at merely 4% and zero grey market premium, signaling cautious sentiment despite the company's growth prospects.
Central Mine Planning IPO Faces Lukewarm Response; QIBs Lead Subscription Drive
Central Mine Planning's IPO garnered modest interest on Day 3 with overall subscription at 1.05x, driven primarily by qualified institutional buyers while retail and HNI segments lag behind.
Powerica IPO Struggles in Early Trading: Tepid Response Raises Concerns About Market Appetite
Powerica Limited's IPO launched on March 24 has received minimal investor interest with just 0.01x subscription on Day 1, signalling weak demand and a potential flat listing ahead.
Veeba Food Eyes IPO Launch: ₹1,650 Crore Fundraise on the Horizon
VRB Consumer Products, the maker of popular Veeba condiments, is gearing up for a public market debut with plans to raise up to $200 million through an IPO, marking a significant milestone for the Indian food industry.
Highness Microelectronics IPO Launch: SME Platform Entry with 16.67% GMP Upside
Highness Microelectronics launched its ₹21.67 crore IPO on the BSE SME platform with a grey market premium suggesting strong investor appetite and potential listing gains.
Veeba Parent Company VRB Consumer Products Files for IPO, Targets $200 Million Fundraising
VRB Consumer Products, the manufacturer behind the popular Veeba sauce and condiments brand, is gearing up for a public market debut with ambitions to raise approximately $200 million through fresh equity issuance.
Manipal Health IPO: Temasek-Backed Hospital Giant Seeks $1 Billion Raise
Manipal Health, the Temasek-backed healthcare provider, has filed its DRHP with SEBI for a proposed IPO targeting $1 billion in capital raise and a $13 billion valuation.
Amir Chand Jagdish Kumar IPO: Grey Market Premium Signals, Day 1 Trading Analysis & Investor Guide
Amir Chand Jagdish Kumar's IPO shows a ₹7 grey market premium on day 1. Explore GMP trends, subscription metrics, and key considerations before investing in this public offering.
Sai Parenteral IPO Shows Slow Day 1 Momentum: Should You Subscribe?
Sai Parenteral's IPO has received modest investor interest on its opening day with just 2% subscription. Here's what you need to know about the issue timeline, GMP, and investment decision.
Manipal Health Enterprises Launches IPO: ₹8,000 Cr Fundraise Signals Healthcare Sector Growth
Temasek-backed Manipal Health Enterprises has filed its DRHP for IPO, planning to raise ₹8,000 crore through fresh issue and investor share sales. The move reflects growing opportunities in India's specialized healthcare market.
11 SEBI-Approved IPOs Ready for Launch: Duroflex, Hero Motors & More
Over 120 companies have secured SEBI approval for IPOs. We spotlight 11 upcoming public issues from major brands like Duroflex, Hero Motors, and Kent R O Systems that could hit the market soon.
JNK India Ltd IPO Gets Thumbs Up From Geojit Financial Services for Long-Term Investors
Geojit Financial Services has issued a 'Subscribe – Long Term' recommendation for JNK India Ltd's IPO, signaling potential value for patient investors seeking exposure to the company's growth prospects.
JNK India Ltd IPO Gets Long-Term Subscribe Rating from Geojit Financial Services
Geojit Financial Services recommends subscribing to JNK India Ltd's IPO for long-term wealth creation, citing positive fundamentals and growth potential.